Vasculopathic Injury and Plasma as Endothelial Rescue in Septic Shock Trial. VIPER-Sepsis (EudraCT no. 2016-000707-81)

Summary

Efficacy and safety of octaplasLG® administration vs. crystalloids (standard) in patients with septic shock - a randomized, controlled, open-label investigator-initiated pilot trial.

Timeline

Start

2016-09-01

Primary completion

2016-11-08

Completion

2016-11-08

Outcome

Outcome not reported

Stopped: “Changing the study design”

Drugs

Indications